The critical role of MLKL in hemorrhagic stroke and the therapeutic potential of its associated protein network
Yi Wang, Moran Xu, Xiaoli Zuo, Sheng Wang, Yong Yu, Zhaobing Gao, Jingbo Qie, Ye Jiang, Fang Huang, Bingqing Xia · 2025
Read The critical role of MLKL in hemorrhagic stroke and the therapeutic potential of its associated protein network by Yi Wang, Moran Xu, Xiaoli Zuo, Sheng Wang, Yong Yu, Zhaobing Gao, Jingbo Qie, Ye Jiang, Fang Huang, Bingqing Xia (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11788306.txt.
Description
Yi Wang and co-authors study a cell-death protein in bleeding stroke in a paper whose text dates to 2024. The protein, MLKL, carries out a form of cell death called necroptosis and feeds swelling in tissue. Earlier work tied it to worse harm after a brain bleed, which made it a tempting drug target. How it does that harm was still unclear.
The team found the protein at high levels in brain tissue from patients, with more protein where injury was worse. In mice, removing the protein's gene did not by itself erase the damage, a result the authors report plainly. Protein mapping then listed partners the protein may act with. The study points drug hunters toward the wider network, not the single protein alone.
Catalog record
| CREATOR | Yi Wang, Moran Xu, Xiaoli Zuo, Sheng Wang, Yong Yu, Zhaobing Gao, Jingbo Qie, Ye Jiang, Fang Huang, Bingqing Xia |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |